David A Siegel1,2, S Jane Henley2, Jennifer M Wike3, A Blythe Ryerson2, Christopher J Johnson4, Judy R Rees5,6, Lori A Pollack2. 1. Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia. 2. Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia. 3. DB Consulting Group, Inc, CDC-NPCR Contractor, Atlanta, Georgia. 4. Cancer Data Registry of Idaho, Boise, Idaho. 5. New Hampshire State Cancer Registry, Lebanon, New Hampshire. 6. Department of Epidemiology, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire.
Abstract
BACKGROUND: Tobacco use data are important when the epidemiology and prognosis of tobacco-associated cancers are being defined. Central cancer registries in 10 National Program of Cancer Registries states pilot-tested the collection of standardized tobacco use variables. This study evaluated the capture of tobacco use data and examined smoking prevalence among cancer patients. METHODS: Participating registries collected data about the use of tobacco-cigarettes, other smoked tobacco, and smokeless tobacco-for cases diagnosed during 2011-2013. The percentage of cases with known tobacco variable values was calculated, and the prevalence of tobacco use was analyzed by the primary cancer site and state. RESULTS: Among 1,646,505 incident cancer cases, 51% had known cigarette use data: 18% were current users, 31% were former users, and 51% reported never using. The percentage of cases with a known status for both other smoked tobacco and smokeless tobacco was 43%, with 97% and 98% coded as never users, respectively. The percent known for cigarette use ranged from 27% to 81% by state and improved from 47% in 2011 to 59% in 2013 for all 10 states combined. The percent known for cigarette use and the prevalence of ever smoking cigarettes were highest for laryngeal cancer and tracheal, lung, and bronchus cancer. CONCLUSIONS: Cancer registrars ascertained cigarette use for slightly more than half of all new cancer cases, but other tobacco-related fields were less complete. Studies to evaluate the validity of specific tobacco-related variables and the ability of cancer registries to capture this information from the medical record are needed to gauge the usefulness of collecting these variables through cancer surveillance systems. Cancer 2018;124:2381-9.
BACKGROUND:Tobacco use data are important when the epidemiology and prognosis of tobacco-associated cancers are being defined. Central cancer registries in 10 National Program of Cancer Registries states pilot-tested the collection of standardized tobacco use variables. This study evaluated the capture of tobacco use data and examined smoking prevalence among cancerpatients. METHODS: Participating registries collected data about the use of tobacco-cigarettes, other smoked tobacco, and smokeless tobacco-for cases diagnosed during 2011-2013. The percentage of cases with known tobacco variable values was calculated, and the prevalence of tobacco use was analyzed by the primary cancer site and state. RESULTS: Among 1,646,505 incident cancer cases, 51% had known cigarette use data: 18% were current users, 31% were former users, and 51% reported never using. The percentage of cases with a known status for both other smoked tobacco and smokeless tobacco was 43%, with 97% and 98% coded as never users, respectively. The percent known for cigarette use ranged from 27% to 81% by state and improved from 47% in 2011 to 59% in 2013 for all 10 states combined. The percent known for cigarette use and the prevalence of ever smoking cigarettes were highest for laryngeal cancer and tracheal, lung, and bronchus cancer. CONCLUSIONS:Cancer registrars ascertained cigarette use for slightly more than half of all new cancer cases, but other tobacco-related fields were less complete. Studies to evaluate the validity of specific tobacco-related variables and the ability of cancer registries to capture this information from the medical record are needed to gauge the usefulness of collecting these variables through cancer surveillance systems. Cancer 2018;124:2381-9.
Authors: Linda S Kinsinger; Charles Anderson; Jane Kim; Martha Larson; Stephanie H Chan; Heather A King; Kathryn L Rice; Christopher G Slatore; Nichole T Tanner; Kathleen Pittman; Robert J Monte; Rebecca B McNeil; Janet M Grubber; Michael J Kelley; Dawn Provenzale; Santanu K Datta; Nina S Sperber; Lottie K Barnes; David H Abbott; Kellie J Sims; Richard L Whitley; R Ryanne Wu; George L Jackson Journal: JAMA Intern Med Date: 2017-03-01 Impact factor: 21.873
Authors: Janet Brigham; Christina N Lessov-Schlaggar; Harold S Javitz; Mary McElroy; Ruth Krasnow; Gary E Swan Journal: Nicotine Tob Res Date: 2008-02 Impact factor: 4.244
Authors: Gina R Kruse; Yuchiao Chang; Jennifer H K Kelley; Jeffrey A Linder; Jonathan S Einbinder; Nancy A Rigotti Journal: Am J Manag Care Date: 2013-07 Impact factor: 2.229
Authors: Maciej Lukasz Goniewicz; Jakub Knysak; Michal Gawron; Leon Kosmider; Andrzej Sobczak; Jolanta Kurek; Adam Prokopowicz; Magdalena Jablonska-Czapla; Czeslawa Rosik-Dulewska; Christopher Havel; Peyton Jacob; Neal Benowitz Journal: Tob Control Date: 2013-03-06 Impact factor: 7.552
Authors: Neeraj K Arora; Ann S Hamilton; Arnold L Potosky; Julia H Rowland; Noreen M Aziz; Keith M Bellizzi; Carrie N Klabunde; Wendy McLaughlin; Jennifer Stevens Journal: J Cancer Surviv Date: 2007-03 Impact factor: 4.442
Authors: Kathleen K Thoburn; Robert R German; Mary Lewis; Phyllis Janie Nichols; Faruque Ahmed; Jeannette Jackson-Thompson Journal: Cancer Date: 2007-04-15 Impact factor: 6.860
Authors: Elyse Phillips; Teresa W Wang; Corinne G Husten; Catherine G Corey; Benjamin J Apelberg; Ahmed Jamal; David M Homa; Brian A King Journal: MMWR Morb Mortal Wkly Rep Date: 2017-11-10 Impact factor: 17.586
Authors: S Jane Henley; Shayne Gallaway; Simple D Singh; Mary Elizabeth O'Neil; Natasha Buchanan Lunsford; Behnoosh Momin; Thomas B Richards Journal: J Womens Health (Larchmt) Date: 2018-10-12 Impact factor: 2.681
Authors: Michael Shayne Gallaway; Bin Huang; Quan Chen; Tom Tucker; Jaclyn McDowell; Eric Durbin; David Siegel; Eric Tai Journal: JCO Clin Cancer Inform Date: 2019-05
Authors: Alex T Ramsey; Ami Chiu; Timothy Baker; Nina Smock; Jingling Chen; Tina Lester; Douglas E Jorenby; Graham A Colditz; Laura J Bierut; Li-Shiun Chen Journal: Transl Behav Med Date: 2020-12-31 Impact factor: 3.046
Authors: Donna Perazzo; Ryan Moore; Nadine A Kasparian; Megan Rodts; Tzipi Horowitz-Kraus; Lori Crosby; Brian Turpin; Andrew F Beck; John Hutton Journal: Pediatr Res Date: 2022-02-04 Impact factor: 3.953
Authors: Paul Krebs; Erin Rogers; Amanda Greenspan; Keith Goldfeld; Lei Lei; Jamie S Ostroff; Bridgette E Garrett; Behnoosh Momin; S Jane Henley Journal: J Registry Manag Date: 2019